Czechia· CZ-0025584

FARESTON

A toremifene product containing toremifene citrate, registered in Czechia by Orion Corporation, Espoo. The same ATC class is registered in 12 of our 19 countries.

ATC L02BA02

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedFARESTONATCL02BA02REGISTER NO.CZ-0025584PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Toremifene is registered in 12 of 19 countries.

Countries holding a registration under ATC L02BA02 (toremifene), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 8 of them publish a price we can compare per daily dose

Toremifene · ATC L02BA02

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of toremifene costs, country by country.

Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Toremifene · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • IT Italy$1.17
  • FR France$0.94
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
TOREMIFENE CITRATE
Manufacturer
Orion Corporation, Espoo
Country
Czechia (CZ)
ATC code
L02BA02
ATC class
Toremifene
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

460 interactions on record for toremifene.

Graded by severity as the source publishes them — 279 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Toremifene · interactions on record

460 records

  • 279 severe
  • 133 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

45 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Toremifene in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All toremifene products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Fareston
  • Liechtenstein · Fareston
  • Norway · Fareston

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a54b419a-5b78-4da4-adae-85e08c9ccbc2
GET /v1/drugs/a54b419a-5b78-4da4-adae-85e08c9ccbc2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL NOB",
  "source": "sukl",
  "strength": "60MG",
  "pack_size": "30",
  "substance": "TOREMIFENE CITRATE",
  "cz_kod_sukl": "0025584",
  "product_type": "CH",
  "substance_codes": "20888",
  "registration_state": "R",
  "registration_number": "EU/1/96/004/001"
}

See everything about toremifene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.